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Background: Kleine-Levin syndrome is a rare sleep disorder of unknown etiology. It is characterized by intermittent
periods of excessive sleepiness, cognitive disturbances and behavioral abnormalities. Nine cases of familial Kleine-Levin
syndrome have been identified, but there are no reported cases describing twins that are affected by the syndrome.
Case presentation: We report the cases of 16-year-old monozygotic twin boys who both suffered from Kleine-Levin
syndrome. In both cases, the onset of the first episode was preceded by an influenza infection. During symptomatic
periods they slept for the entire day except for meals and bathroom visits. Actimetry recordings revealed that during
symptomatic periods, daily activity was lower than that of asymptomatic periods, on the other hand, activity during the
night was significantly higher in symptomatic periods than asymptomatic periods. Polysomnography (PSG) data during
symptomatic periods revealed a decrease in sleep efficiency. Human leukocyte antigen (HLA) typing revealed no
DQB1*02 loci. They were administered lithium carbonate but the beneficial effect was limited.
Conclusions: Our observations suggest that Kleine-Levin syndrome may be due to genetic and autoimmune
processes, although etiologic relationship to specific HLA type remains controversial.
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Kleine-Levin syndrome is a rare idiopathic form of epi-
sodic hypersomnia that typically occurs during adoles-
cence. The cardinal clinical features are recurrent
hypersomnia, accompanied by cognitive disturbances
and behavioral abnormalities [1]. The most typical form
of classical Kleine-Levin syndrome is associated with
hyperphagia [2,3], although hyperphagia is now optional
after change of the criteria. Hypersexuality, behavioral
disinhibition, delusions, autonomic alteration and hallu-
cinations have also been described, but the patients
show normal cognitive function and behavior between
attacks. The pathogenesis of Kleine-Levin syndrome is
not yet known. Although most cases of recurrent hyper-
somnia are sporadic, the occurrence of nine familial
cases indicate that there may be a genetic predisposition
to the syndrome [4-8] However, no cases of twins
affected with Kleine-Levin syndrome have been reported* Correspondence: kkume@kumamoto-u.ac.jp
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reproduction in any medium, provided the or[9]. In this case study we describe monozygotic twins
suffering from the syndrome. This is the first case report
describing twins affected with Kleine-Levin syndrome
thereby supporting the theory that there is an underlying
genetic predisposition to the syndrome.
Case presentation
Case 1
A 15-year-old boy visited our hospital complaining of re-
current episodes of hypersomnia. His first attack of
hypersomnia started at the age of 13, one month after
he had been treated with zanamivir for an influenza in-
fection. The episodes of hypersomnia occurred once a
month and each lasted for 7 to 10 days. During the
symptomatic periods, the patient slept for the entire day
except for meals and bathroom visits. He did not exhibit
compulsive eating but instead ate less than usual. When
questioned, he gave no answer and he later reported that
it was difficult to understand what he was told. During
the episode, he experienced visual hallucinations such as
a fireball. Often, the attacks were immediately preceded
by flu-like symptoms. Both of the twins are activetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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them did not want to play during and immediately after
the episodes. A physical examination of the patient was
unremarkable. Between spells, he appeared animated
and displayed normal social behavior.
Actimetry recording showed that during attacks, daily
activity was lower than that of asymptomatic periods
(Figure 1). On the other hand, activity during the night
was significantly higher than in symptomatic periods. PSG
was performed during a symptomatic night and revealed a
decrease in sleep efficiency (63.6%, Table 1). In addition,
frequent awakenings were observed during the nocturnal
PSG (Figure 2A). HLA typing revealed the presence of the
DQB1*0302/0601, DRB1*0407/1502 allele.Figure 1 Locomotor activity recorded using actimetry. (A) Actogram re
1. The actograms show the activity for the period between episodes and that
Based on bed time of the period between episodes, daily activity (0:00–24:00)
represented as the mean ± SEM. Asterisks indicate statistically significant diffeMedication using lithium carbonate was initiated and
gradually increased to 1000 mg/day with drug monitor-
ing to keep the concentration within therapeutic window
(0.8 – 1.2 mEq/l), and it reduced the frequency of the
spells. As of November 2011, he has experienced 23
episodes.
Case 2
The monozygotic twin brother of the individual
described in case 1 suffered from repeated hypersomno-
lent spells from the age of 14. The first episode was pre-
ceded by an influenza infection that was treated with
zanamivir. During episodes, he remained in bed either
sleeping or physically inactive. His symptoms lasted forcords graphed as a double plot showing the locomotor activity of case
of symptomatic periods. (B) Statistical analysis of locomotor activity.
was divided into sleep (0:00–7:00) and active (7:00–24:00) times. Data are
rences as determined by a Student’s t-test (p< 0.0005).
Table 1 Analysis of sleep architecture during symptomatic
period (case #1) and asymptomatic period (case #2)
Case #1 Case #2
Stage minutes (%) symptomatic period asymptomatic period
Wake 207 (36.4) 13.5 (3.6)
Stage 1 55 (9.7) 37 (10)
Stage 2 130 (22.8) 150 (40.5)
Stage 3 45 (7.9) 21 (5.7)
Stage 4 39 (6.9) 53 (14.3)
REM 94 (16.5) 98 (26.4)
Sleep latency 15 7
Sleep efficiency 63.6% 96.4%
Total bed time 569 370
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between spells. He did not exhibit compulsive eating,
but he preferred unusually (for him) sour foods. He had
difficulty with verbal communication but could write
down an answer when questioned. This speech abnor-
mality became less prominent with subsequent spells.
Attacks were immediately preceded by a flu-like illness.
Between spells, he displayed no psychiatric disorder and
maintained normal social and intellectual functions.
Actimetry recording showed that during attacks, activity
during the day was lower than that of asymptomatic peri-
ods, on the other hand, the activity during night was signifi-
cantly higher in symptomatic periods. PSG was performed
during an asymptomatic night but revealed no significantFigure 2 Hypnograms of the twin boys. (A) Hypnograms of case #1 dur
asymptomatic period.findings (Table 1, Figure 2B). HLA typing revealed the pres-
ence of the DQB1*0302/0601, DRB1*0407/1502 allele.
Medication using lithium carbonate was initiated and
gradually increased to 600 mg/day with drug monitor-
ing, but it neither prevented nor reduced the duration of
the spells. As of November 2011, he has experienced 10
episodes.
Conclusions and discussion
Sleep disorders involve genetic susceptibility, environmen-
tal effects, and interactions between these factors [10].
The heritability of sleep patterns has been reported previ-
ously in studies of monozygotic twins, which may assist in
the identification of genes involved in sleep disorders [11].
An understanding of sleep regulation at the molecular
level is essential in the identification of targets for the
treatment of sleep disorders. Although several familial
cases of Kleine-Levin syndrome were reported [4-8], no
cases of twins affected with the disease reported [9]. The
cases of Kleine-Levin syndrome reported here are excep-
tional as they occur in monozygotic twins. For both
patients the age of onset was similar and the symptoms
and clinical course were typical. Actimetry demonstrated
increased nocturnal activity and decreased daytime activ-
ity during symptomatic periods. PSG revealed low sleep
efficiency during attacks, a decreased amount of SWS,
sleep onset REM periods and sleep fragmentation. These
PSG data are consistent with a previous report [12]. Des-
pite the reduced amplitude in the circadian rhythm of ac-
tivity, a previous endocrinological study reported no link
between an underlying circadian disorder and recurrenting symptomatic period. (B) Hypnograms of case #2 during
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[15] of thalamus have been reported during the symptom-
atic period of Kleine-Levin syndrome with Tc-99 m ECD
single photon emission tomography (SPECT) which sug-
gest that there is an involvement of this brain tissue in the
acute clinical presentation. Based on the generally young
age of onset, the recurrence of symptoms and the frequent
infectious trigger, an autoimmune etiology for Kleine-Levin
syndrome has been suggested. In terms of genetic suscepti-
bility, it has been suggested that the gene polymorphism of
HLA-DQB1 is associated with recurrent hypersomnia [16].
However, in a more recent study using a larger independ-
ent sample, HLA DR and DQ alleles did not differ between
cases and control subjects [17]. Both of the subjects in the
case study reported here had been treated for an influenza
infection at the onset of the first episode, but we did not
identify DQB1*02. As for narcolepsy, which is a representa-
tive primary hypersomnia and has an established linkage
with HLA subtype (HLA-DR2, DQB1*0602), increased
onset following 2009 H1N1 winter influenza pandemic
were reported recently [18]. Association with HLA is now
controversial but the involvement of an autoimmune
process remains plausible. Genome-wide mapping studies
should be performed using the known familial cases to
search for potential linkage. Finally, while this manuscript
was under review, another monozygotic twin pair concord-
ant for Kleine-Levin syndrome is reported [19]. Interest-
ingly, they also found DQB1*0302/*0601 allele in the twins.Consent
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